Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Cancers|November 9, 2024
Awareness of the Link Between Human Papilloma Virus Infection and Head and Neck Cancer Among the General Population and Practitioners: A Literature ReviewAlicia Tosoni, Linda Galvani, Vincenzo Di Nunno, et al.
Cancer|May 25, 2005
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Giovanna Cavallo, Michele Reni, et al.
Scientific Reports|March 15, 2018
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1<sup>105GGT</sup>) in brain tumors of a cohort of Italian patientsGiorgia Acquaviva, Michela Visani, Dario de Biase, et al.
Cancers|November 27, 2024
Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort StudySofia Asioli, Lidia Gatto, Uri Vardy, et al.
Journal of Neuro-Oncology|April 29, 2006
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumorsLuciano Scopece, Enrico Franceschi, Giovanna Cavallo, et al.
Journal of Neuro-Oncology|June 28, 2005
Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisEnrico Franceschi, Giovanna Cavallo, Luciano Scopece, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Treatment of recurrent glioblastoma: state-of-the-art and future perspectivesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Neuro-Oncology|July 28, 2017
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteriaMichela Visani, Giorgia Acquaviva, Gianluca Marucci, et al.
Cancers|March 28, 2026
Ultrasound-Based Therapies in Primary Central Nervous System TumorsGiovanni Dima, Alessandro Olivari, Vincenzo Di Nunno, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
IDH1 Non-Canonical Mutations and Survival in Patients with GliomaEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Cancers|November 9, 2024
Awareness of the Link Between Human Papilloma Virus Infection and Head and Neck Cancer Among the General Population and Practitioners: A Literature ReviewAlicia Tosoni, Linda Galvani, Vincenzo Di Nunno, et al.
Cancer|May 25, 2005
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Giovanna Cavallo, Michele Reni, et al.
Scientific Reports|March 15, 2018
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1<sup>105GGT</sup>) in brain tumors of a cohort of Italian patientsGiorgia Acquaviva, Michela Visani, Dario de Biase, et al.
Cancers|November 27, 2024
Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort StudySofia Asioli, Lidia Gatto, Uri Vardy, et al.
Journal of Neuro-Oncology|April 29, 2006
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumorsLuciano Scopece, Enrico Franceschi, Giovanna Cavallo, et al.
Journal of Neuro-Oncology|June 28, 2005
Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisEnrico Franceschi, Giovanna Cavallo, Luciano Scopece, et al.
Expert Review of Anticancer Therapy|August 18, 2020
Treatment of recurrent glioblastoma: state-of-the-art and future perspectivesVincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Journal of Neuro-Oncology|July 28, 2017
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteriaMichela Visani, Giorgia Acquaviva, Gianluca Marucci, et al.
Cancers|March 28, 2026
Ultrasound-Based Therapies in Primary Central Nervous System TumorsGiovanni Dima, Alessandro Olivari, Vincenzo Di Nunno, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
IDH1 Non-Canonical Mutations and Survival in Patients with GliomaEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Pageof 17